|
|
Clinician Update on Measles Cases and Outbreaks in the United States |
|
Overview |
|
This year, record-breaking numbers of measles cases and outbreaks have been reported in the United States, despite measles being declared eliminated in 2000. While the risk of widespread measles remains low for the general population due to high population-level immunity, measles importations continue to occur. Outbreaks of three or more related cases continue to be reported, especially in communities with low vaccination coverage. Healthcare providers should remain vigilant to rapidly recognize measles and take steps to mitigate its spread.
During this COCA Call, presenters will discuss the current epidemiology of measles in the United States and address the most common questions from clinicians about preventing, identifying, and testing for measles. Presenters will also summarize measles, mumps, and rubella (MMR) vaccination recommendations and considerations.
If you are unable to attend the live session of this COCA Call, the closed-captioned video and transcript will be available on the COCA Call webpage approximately one week after the live session.
The slide set will be available on the day of the call on the COCA Call webpage under Webinar.
Free Continuing Education (CE) will be offered for this COCA Call.
Registration is not required. |
Measles rash usually begins as flat red spots on the face, then spreads downward to the trunk.
Date: Thursday, August 14, 2025
Time: 2:00 PM – 3:00 PM ET Webinar Link: https://us02web.zoom.us/j/83810758213?pwd=ydklairhtjmgin5FGYCVkXwjU8xurU.1
Webinar ID: 838 1075 8213 Passcode: 890532
Phone one-tap: +16469313860,,83810758213#,,,,*890532#
+13017158592,,83810758213#,,,,*890532#
Audio: +1 646 558 8656 |
|
Activity-specific Objectives |
|
At the conclusion of the session, the participant will be able to accomplish the following:
|
|
COCA Call Objectives |
|
|
Presenters |
|
CAPT David Sugerman, MD, MPH, FACEP, USPHS Chief (Acting), Viral Vaccine Preventable Diseases Branch Division of Viral Diseases National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention
Adria Mathis, MSPH Epidemiologist Division of Viral Diseases National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention
Dan Filardo, MD Medical Officer Division of Viral Diseases National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention
|
|
Instructions for Obtaining Continuing Education |
|
To receive continuing education (CE) for WC4520R-081425—Clinician Update on Measles Cases and Outbreaks in the United States, please visit CDC TRAIN and search for the course in the Course Catalog using WC4520R-081425. Follow the steps below by September 15, 2025. The registration code is COCA081425.
To receive continuing education (CE) for WD4520R-081425—Clinician Update on Measles Cases and Outbreaks in the United States, please visit CDC TRAIN and search for the course in the Course Catalog using WD4520R-081425. Follow the steps below between September 16, 2025, and September 16, 2027.
1. Register for and complete the course. 2. Pass the post-assessment at 75%. 3. Complete the evaluation. 4. Visit Your Learning to access your certificates and transcript. |
|
Accreditation Statement |
|
|
In support of improving patient care, The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
|
CME: The Centers for Disease Control and Prevention designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA CME: Credit Designation Statement – Live The Centers for Disease Control and Prevention has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
CNE: The Centers for Disease Control and Prevention designates this activity for 1 nursing contact hours.
CPE: The Centers for Disease Control and Prevention designated this Knowledge-based event for pharmacists to receive 0.1 CEUs in pharmacy education. The Universal Activity Number is JA4008229-0000-25-053-L04P and enduring is JA4008229-0000-25-054-H04-P.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 1. Continuing Competency credits available are 1. CDC provider number 98614.
AAVSB/RACE: This program has been submitted (but not yet approved) for 1 hours of continuing education credit in jurisdictions which recognize AAVSB RACE approval; however, participants should be aware that some boards have limitations on the number of hours accepted in certain categories or restrictions on certain methods of delivery of continuing education.
For Certified Public Health Professionals (CPH): The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credits for this program.
DISCLOSURE: In compliance with continuing education requirements, all planners and presenters/moderators must disclose all financial relationships, in any amount, with ineligible companies over the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.
CDC, our planners, and presenters/moderators wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.
|
|
The Office of Emergency Risk Communication in the Office of Communications is responsible for the management of all COCA Products. For information about this update or other clinical issues, or to send your feedback, please contact us at coca@cdc.gov
|
|
|
CDC and HHS logos are the exclusive property of the Department of Health and Human Services and may not be used for any purpose without prior express written permission. Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services. |
|
Links to non-federal organizations are provided solely as a service to our users. Links do not constitute an endorsement of any organization by CDC or the federal government, and none should be inferred. CDC is not responsible for the content of the individual organizations. |